Document is current

Article History

Accepted: 9 May 2023

First Online: 30 May 2023

Declarations

:

: No financial support was received for the completion of this study. WZ acknowledges support from a Michael Smith Foundation for Health Research (MSFHR) Scholar Award. MSFHR had no role in the design, methods, data collection, analysis, data interpretation, or preparation of the article.

: Authors ILB, AJS, and WZ have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the materials discussed in this manuscript. ILB was a consultant for Voyage Biomedical Inc and holds shares in Voyage Biomedical Inc., Neuraura Biotech Inc., and Protxx Inc. Voyage Biomedical Inc., Neuraura Biotech Inc., and Protxx Inc. had no role in the design, methods, participant recruitment, data collection, analysis, data interpretation, or preparation of this article.

: This qualitative study was granted ethical approval by the University of British Columbia Behavioural Research Ethics Board (H21-03175).

: Informed consent was obtained from each participant prior to commencing all interviews. Due to the sensitive nature of this topic, a consent template has been included with this submission.

: N/A.

: Due to the sensitive nature of this topic and the proprietary implications of the information discussed, complete transcripts have not been made publicly available. Anonymized transcripts have been made available to the journal only.

: N/A.

: ILB and WZ were responsible for conception and study design, data collection, data analysis, data interpretation and manuscript preparation. AJS was responsible for data analysis, data interpretation, and manuscript preparation.